Exact Sciences Corporation EXAS has launched the Cancerguard test, a new multi-cancer early detection (MCED) blood test now offered as a laboratory-developed test (LDT) in the United States.

The tests look for bits of altered DNA that cancer cells shed into the bloodstream. The screening technology holds hope of finding cancers early, when they might be cured.

Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan ...

Access to rapidly developing diagnostic technology such as blood-based biomarkers for early detection and subsequent ...

While patients wait to hear back from their doctors about test results, many turn to AI assistants for answers. There are ...

Two years after Abbott landed FDA clearance for a hand-held blood test that could detect signs of mild traumatic brain injuries (TBIs) in the span of about 15 minutes, the concussion-spotting test is ...

CT scan of a brain of a patient with subdural hemorrhage, interhemispheric hemorrhage and cerebral edema from trauamatic brain injury (TBI). (CT scan of a brain of a patient with subdural hemorrhage, ...